Bourgeon Capital Management’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3
| Closed | -$5 | – | 253 |
|
|
2023
Q4 | $5 | Sell |
3
-8
| -73% | -$11 | ﹤0.01% | 400 |
|
|
2023
Q3 | $16 | Hold |
11
| – | – | ﹤0.01% | 397 |
|
|
2023
Q2 | $30 | Hold |
11
| – | – | ﹤0.01% | 335 |
|
|
2023
Q1 | $23 | Sell |
11
-2
| -15% | -$6 | ﹤0.01% | 321 |
|
|
2022
Q4 | $39 | Hold |
13
| – | – | ﹤0.01% | 372 |
|
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 414 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 298 |
|
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 299 |
|
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 279 |
|
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 290 |
|
|
2021
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 287 |
|
|
2021
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 297 |
|
|
2020
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 301 |
|
|
2020
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 309 |
|
|
2020
Q2 | $0 | Buy |
13
+2
| +18% | +$14 | ﹤0.01% | 267 |
|
|
2020
Q1 | $0 | Buy |
+11
| New | +$96 | ﹤0.01% | 267 |
|
|
2019
Q4 | – | Sell |
-11
| Closed | – | – | 240 |
|
|
2019
Q3 | $0 | Buy |
+11
| New | +$64 | ﹤0.01% | 237 |
|
|
2016
Q4 | – | Sell |
-505
| Closed | -$93K | – | 99 |
|
|
2016
Q3 | $93K | Buy |
505
+166
| +49% | +$21.7K | 0.06% | 89 |
|
|
2016
Q2 | $18K | Sell |
339
-41
| -11% | -$11.8K | 0.01% | 90 |
|
|
2016
Q1 | $160K | Buy |
380
+83
| +28% | +$43.8K | 0.11% | 87 |
|
|
2015
Q4 | $200K | Buy |
297
+19
| +7% | +$13.9K | 0.13% | 84 |
|
|
2015
Q3 | $180K | Buy |
278
+16
| +6% | +$12.2K | 0.13% | 91 |
|
|
2015
Q2 | $229K | Buy |
262
+30
| +13% | +$35.3K | 0.14% | 96 |
|
|
2015
Q1 | $383K | Buy |
232
+48
| +26% | +$85.7K | 0.23% | 77 |
|
|
2014
Q4 | $280K | Buy |
184
+12
| +7% | +$21.8K | 0.17% | 91 |
|
|
2014
Q3 | $351K | Buy |
172
+4
| +2% | +$10.6K | 0.2% | 83 |
|
|
2014
Q2 | $552K | Buy |
168
+28
| +20% | +$64.6K | 0.3% | 73 |
|
|
2014
Q1 | $303K | Buy |
140
+73
| +109% | +$175K | 0.19% | 82 |
|
|
2013
Q4 | $134K | Buy |
+67
| New | +$142K | 0.09% | 92 |
|
Other funds holding MBOT
AA
HH
TSS
Bourgeon Capital Management's MBOT Position: Q1 2024 in Review
Bourgeon Capital Management sold out of Microbot Medical (MBOT) in Q1 2024, closing a stake of 3 shares — an estimated $5 sold.
Bourgeon Capital Management first reported a position in MBOT in Q4 2013 and held it in 29 quarters. The position peaked at $552K in Q2 2014. 33 funds tracked by Wall St. Rank hold MBOT as of Q1 2024.
- Bourgeon Capital Management reported no remaining Microbot Medical position as of Q1 2024 after selling out during the quarter.
- Bourgeon Capital Management sold 3 Microbot Medical shares in Q1 2024, an estimated $5.
- Bourgeon Capital Management first reported a position in Microbot Medical in Q4 2013 and held it in 29 quarters.
- Bourgeon Capital Management's Microbot Medical position peaked at $552K in Q2 2014.
- 33 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2024.
Based on Bourgeon Capital Management's 13F filing for Q1 2024, filed 19 Apr 2024.